Published in Int J Health Care Finance Econ on September 01, 2007
Global trends in rates of peritoneal dialysis. J Am Soc Nephrol (2012) 2.29
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Int J Health Care Finance Econ (2007) 1.40
Disparities in kidney transplant outcomes: a review. Semin Nephrol (2010) 1.21
The organization and financing of dialysis and kidney transplantation services in New Zealand. Int J Health Care Finance Econ (2007) 1.02
Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003. Am J Kidney Dis (2010) 1.00
International study of health care organization and financing: development of renal replacement therapy in Germany. Int J Health Care Finance Econ (2007) 0.96
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ (2007) 0.93
The financing and organization of medical care for patients with end-stage renal disease in Sweden. Int J Health Care Finance Econ (2007) 0.92
The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ (2007) 0.91
The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ (2007) 0.91
Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol (2012) 0.88
International Study of Health Care Organization and Financing for end-stage renal disease in France. Int J Health Care Finance Econ (2007) 0.83
The organization and financing of end-stage renal disease in Spain. Int J Health Care Finance Econ (2007) 0.82
Dialysis: Choice of dialysis--what to do with economic incentives. Nat Rev Nephrol (2012) 0.81
Clinician beliefs and attitudes about home haemodialysis: a multinational interview study. BMJ Open (2012) 0.79
The organization and funding of the treatment of end-stage renal disease in Australia. Int J Health Care Finance Econ (2007) 0.79
Novel drugs and intervention strategies for the treatment of chronic kidney disease. Br J Clin Pharmacol (2013) 0.78
Comprehensive and personalized care of the hemodialysis patient in tassin, france: a model for the patient-centered medical home for subspecialty patients. ISRN Nephrol (2012) 0.78
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol (2016) 0.77
International Study of Health Care Organization and Financing of renal services in England and Wales. Int J Health Care Finance Econ (2007) 0.76
Anemia and thrombocytopenia in acute and chronic renal failure. Int J Hematol Oncol Stem Cell Res (2013) 0.76
The EVEREST study: an international collaboration. NDT Plus (2009) 0.76
Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clin Kidney J (2014) 0.75
A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events. Eur J Health Econ (2016) 0.75
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Geography and the debate over Medicare reform. Health Aff (Millwood) (2003) 9.85
A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51
Predictions of hospital mortality rates: a comparison of data sources. Ann Intern Med (1997) 3.72
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis (2004) 2.82
Variation profiles of common surgical procedures. Surgery (1998) 2.44
Prices and availability of pharmaceuticals: evidence from nine countries. Health Aff (Millwood) (2004) 2.33
Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med (1994) 2.24
Referral for dialysis in Ontario. Arch Intern Med (1996) 2.13
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 1.83
Impact of risk-adjusting cesarean delivery rates when reporting hospital performance. JAMA (1998) 1.54
International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol (2006) 1.49
Analyzing hospital mortality. The consequences of diversity in patient mix. JAMA (1991) 1.43
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Int J Health Care Finance Econ (2007) 1.40
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant (1999) 1.39
Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.37
Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2002) 1.34
End-stage renal care in developing countries: the India experience. Ren Fail (2004) 1.28
Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res (2006) 1.14
High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis (2004) 1.03
Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. Am J Kidney Dis (2001) 1.02
The organization and financing of dialysis and kidney transplantation services in New Zealand. Int J Health Care Finance Econ (2007) 1.02
Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units. Kidney Int (2006) 1.01
Benign moral hazard and the cost-effectiveness analysis of insurance coverage. J Health Econ (1990) 1.01
[Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis]. Nephrologie (2001) 0.98
International study of health care organization and financing: development of renal replacement therapy in Germany. Int J Health Care Finance Econ (2007) 0.96
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ (2007) 0.93
The financing and organization of medical care for patients with end-stage renal disease in Sweden. Int J Health Care Finance Econ (2007) 0.92
Dialyzer reuse--part II: advantages and disadvantages. Semin Dial (2006) 0.91
The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ (2007) 0.91
The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ (2007) 0.91
Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease. Int J Health Care Finance Econ (2007) 0.89
U.S. health care costs: the untold true story. Health Aff (Millwood) (1993) 0.85
An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Apher Dial (2005) 0.85
[Dialysis and transplant patients Registry of the Spanish Society of Nephrology]. Nefrologia (2005) 0.85
International Study of Health Care Organization and Financing for end-stage renal disease in France. Int J Health Care Finance Econ (2007) 0.83
The organization and financing of end-stage renal disease in Spain. Int J Health Care Finance Econ (2007) 0.82
Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities. Health Econ (2005) 0.80
Need for an incentive-based reimbursement policy toward quality care for dialysis patient management. Kidney Int (2000) 0.79
The organization and funding of the treatment of end-stage renal disease in Australia. Int J Health Care Finance Econ (2007) 0.79
International Study of Health Care Organization and Financing of renal services in England and Wales. Int J Health Care Finance Econ (2007) 0.76
Organ transplantation and brain-death in Japan. Cultural, legal and bioethical background. Ann Transplant (1998) 0.76
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]. G Ital Nefrol (2004) 0.76
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med (2009) 6.08
Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med (2004) 3.96
Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2003) 3.90
Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int (2002) 3.79
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 3.37
Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl (2003) 2.68
Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int (2003) 2.65
P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) (2009) 2.49
Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int (2002) 2.16
Bending the cost curve through market-based incentives. N Engl J Med (2012) 2.13
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.93
Integrated delivery networks: a detour on the road to integrated health care? Health Aff (Millwood) (2002) 1.91
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2002) 1.87
Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2003) 1.86
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 1.83
Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2003) 1.72
Effect of tiered prescription copayments on the use of preferred brand medications. Med Care (2003) 1.58
Accountable care organizations may have difficulty avoiding the failures of integrated delivery networks of the 1990s. Health Aff (Millwood) (2012) 1.57
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. Am J Manag Care (2003) 1.46
Kidney and pancreas transplantation. Am J Transplant (2003) 1.45
Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res (2007) 1.35
Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2002) 1.34
Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Am J Med Genet A (2003) 1.33
Measuring the effects of work loss on productivity with team production. Health Econ (2006) 1.31
Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood) (2005) 1.28
Short- and long-term mortality after an acute illness for elderly whites and blacks. Health Serv Res (2008) 1.26
Incentive-compatible guaranteed renewable health insurance premiums. J Health Econ (2006) 1.23
DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif (2004) 1.21
Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2005) 1.20
Is health insurance affordable for the uninsured? J Health Econ (2006) 1.19
Transitions of elders between long-term care and hospitals. Policy Polit Nurs Pract (2009) 1.18
High-value transitional care: translation of research into practice. J Eval Clin Pract (2011) 1.17
Market reform in New Jersey and the effect on mortality from acute myocardial infarction. Health Serv Res (2003) 1.14
Chronic illness, treatment choice and workforce participation. Int J Health Care Finance Econ (2003) 1.12
Community-level uninsurance and the unmet medical needs of insured and uninsured adults. Health Serv Res (2006) 1.11
International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney Int (2010) 1.08
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis (2004) 1.06
How to present the business case for healthcare quality to employers. Appl Health Econ Health Policy (2005) 1.04
High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis (2004) 1.03
Organ donation in the United States. Am J Transplant (2003) 0.98
Is lower 30-day mortality posthospital admission among blacks unique to the Veterans Affairs health care system? Med Care (2007) 0.98
Random sample (DOPPS) versus census-based (registry) approaches to kidney disease research. Blood Purif (2003) 0.97
Evaluation of the ESRD managed care demonstration operations. Health Care Financ Rev (2003) 0.96
Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults. J Comp Eff Res (2014) 0.94
The financing and organization of medical care for patients with end-stage renal disease in Sweden. Int J Health Care Finance Econ (2007) 0.92
Early readmission and length of hospitalization practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int (2004) 0.91
Engaging older adults in their transitional care: what more needs to be done? J Comp Eff Res (2013) 0.91
The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ (2007) 0.91
Patient selection in the ESRD managed care demonstration. Health Care Financ Rev (2003) 0.91
Quality of life and patient satisfaction: ESRD managed care demonstration. Health Care Financ Rev (2003) 0.90
Time preference and its relationship with age, health, and survival probability. Judgm Decis Mak (2009) 0.88
Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 0.86
Keeping health insurance tax credits on the table. JAMA (2004) 0.85
Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. Am J Manag Care (2005) 0.84
ESRD managed care demonstration: financial implications. Health Care Financ Rev (2003) 0.83
Getting real performance out of pay-for-performance. Milbank Q (2008) 0.81
Physicians' career satisfaction, quality of care and patients' trust: the role of community uninsurance. Health Econ Policy Law (2007) 0.80
Guaranteed renewability and the problem of risk variation in individual health insurance markets. Health Aff (Millwood) (2003) 0.80
Linkages between nursing and the quality of patient care: a 2-year comparison. Med Care (2013) 0.79
Preventive care in managed care and fee-for-service plans: is it cost effective? Manag Care Interface (2003) 0.79
Accountable care organizations: back to the future? LDI Issue Brief (2013) 0.78
Optimizing hemodialysis practices in Canada could improve patient survival. CANNT J (2007) 0.78
DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Canada. Nephrol News Issues (2007) 0.78
Complementary and alternative medicine: personal preference or low cost option? LDI Issue Brief (2004) 0.78
Difference in the use of preventive services between fee-for-service plans and HMOs: is more better? Am J Manag Care (2003) 0.77
[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France]. Nephrol Ther (2008) 0.76
TOO SICK TO START: ENTREPRENEUR'S HEALTH AND BUSINESS ENTRY IN TOWNSHIPS AROUND DURBAN, SOUTH AFRICA. J Dev Entrep (2010) 0.75
A COMPARATIVE EVALUATION OF TWO INTERVENTIONS FOR EDUCATOR TRAINING IN HIV/AIDS IN SOUTH AFRICA. Int J Educ Dev Using Inf Commun Technol (2010) 0.75
How health affects small business in South Africa. LDI Issue Brief (2007) 0.75
Trends in cadaveric organ donation in the United States: 1990-1999. Clin Transpl (2002) 0.75
"Play-or-pay" insurance reforms for employers--confusion and inequity. N Engl J Med (2009) 0.75
Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors. Manag Care Interface (2005) 0.75
Health care reform in perspective. N Engl J Med (2009) 0.75
Asymmetric Thinking about Return on Investment. N Engl J Med (2016) 0.75
Introduction: the Interdisciplinary Nursing Quality Research Initiative. Med Care (2013) 0.75
The role of MD and MBA training in the professional development of a physician: a survey of 30 years of graduates from the Wharton Health Care Management Program. Acad Med (2014) 0.75
Market reform in New Jersey and quality of care: a cautionary tale. LDI Issue Brief (2003) 0.75
Continuity of Care: The Transitional Care Model. Online J Issues Nurs (2015) 0.75
Equity and costs. Law Med Health Care (1985) 0.75
Lessons to improve the efficiency and equity of health reform. Hastings Cent Rep (2012) 0.75